REST mediates androgen receptor actions on gene repression and predicts early recurrence of prostate cancer

Nucleic Acids Research

Volumn 42, Issue 2, 2014, Pages 999-1015

  Svensson, Charlotte ^a   Ceder, Jens ^b   Iglesias Gato, Diego ^a   Chuan, Yin Choy ^a   Pang, See Tong ^c   Bjartell, Anders ^b   Martinez, Roxana Merino ^d   Bott, Laura ^d   Helczynski, Leszek ^e   Ulmert, David ^b,f   Wang, Yuzhuo ^g   Niu, Yuanjie ^h   Collins, Colin ^g   Flores Morales, Amilcar ^a  

^a University of Copenhagen   (Denmark)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^d KAROLINSKA INSTITUTE   (Sweden)

^e Karolinska Institute ^*  (Sweden)

^f MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^g UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^h TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; AURORA A KINASE; ENZALUTAMIDE; REPRESSOR ELEMENT SILENCING TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CANCER RECURRENCE; CARCINOGENESIS; CASTRATION RESISTANT PROSTATE CANCER; CELL CYCLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENE REPRESSION; GLEASON SCORE; HUMAN; HUMAN TISSUE; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; NERVE CELL DIFFERENTIATION; NEUROENDOCRINE SYSTEM; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; PROSTATECTOMY; PROTEIN METABOLISM; RECEPTOR BINDING; RECURRENT DISEASE; TISSUE MICROARRAY;

CELL LINE, TUMOR; CELL TRANSDIFFERENTIATION; CHROMATIN; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; NERVE TISSUE PROTEINS; PROMOTER REGIONS, GENETIC; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; REPRESSOR PROTEINS;

EID: 84893296911     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkt921     Document Type: Article

References (59)

1. Epstein, J.I., Amin, M., Boccon-Gibod, L., Egevad, L., Humphrey, P.A., Mikuz, G., Newling, D., Nilsson, S., Sakr, W., Srigley, J.R. et al. (2005) Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens. Scand. J. Urol. Nephrol., 34-63.
2. Taichman, R.S., Loberg, R.D., Mehra, R. and Pienta, K.J. (2007) The evolving biology and treatment of prostate cancer. J. Clin. Invest., 117, 2351-2361.
3. Pienta, K.J. and Bradley, D. (2006) Mechanisms underlying the development of androgen-independent prostate cancer. Clin. Cancer Res., 12, 1665-1671.
4. Schaeffer, E.M., Marchionni, L., Huang, Z., Simons, B., Blackman, A., Yu, W., Parmigiani, G. and Berman, D.M. (2008) Androgen-induced programs for prostate epithelial growth and invasion arise in embryogenesis and are reactivated in cancer. Oncogene, 27, 7180-7191.
5. Heinlein, C.A. and Chang, C. (2004) Androgen receptor in prostate cancer. Endocr. Rev., 25, 276-308.
6. Wang, X., Kruithof-de Julio, M., Economides, K.D., Walker, D., Yu, H., Halili, M.V., Hu, Y.P., Price, S.M., Abate-Shen, C. and Shen, M.M. (2009) A luminal epithelial stem cell that is a cell of origin for prostate cancer. Nature, 461, 495-500.
7. Taylor, R.A., Toivanen, R. and Risbridger, G.P. (2010) Stem cells in prostate cancer: treating the root of the problem. Endocr. Relat. Cancer, 17, R273-R285.
8. Vander Griend, D.J., Karthaus, W.L., Dalrymple, S., Meeker, A., DeMarzo, A.M. and Isaacs, J.T. (2008) The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cells. Cancer Res., 68, 9703-9711.
9. Taplin, M.E., Rajeshkumar, B., Halabi, S., Werner, C.P., Woda, B.A., Picus, J., Stadler, W., Hayes, D.F., Kantoff, P.W., Vogelzang, N.J. et al. (2003) Androgen receptor mutations in androgenindependent prostate cancer: Cancer and Leukemia Group B Study 9663. J. Clin. Oncol., 21, 2673-2678.
10. Brinkmann, A.O., Blok, L.J., de Ruiter, P.E., Doesburg, P., Steketee, K., Berrevoets, C.A. and Trapman, J. (1999) Mechanisms of androgen receptor activation and function. J. Steroid Biochem. Mol. Biol., 69, 307-313.
11. Wang, Q., Li, W., Liu, X.S., Carroll, J.S., Janne, O.A., Keeton, E.K., Chinnaiyan, A.M., Pienta, K.J. and Brown, M. (2007) A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth. Mol. Cell, 27, 380-392.
12. Lupien, M., Eeckhoute, J., Meyer, C.A., Wang, Q., Zhang, Y., Li, W., Carroll, J.S., Liu, X.S. and Brown, M. (2008) FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription. Cell, 132, 958-970.
13. Massie, C.E., Adryan, B., Barbosa-Morais, N.L., Lynch, A.G., Tran, M.G., Neal, D.E. and Mills, I.G. (2007) New androgen receptor genomic targets show an interaction with the ETS1 transcription factor. EMBO Rep., 8, 871-878.
14. Jia, L., Berman, B.P., Jariwala, U., Yan, X., Cogan, J.P., Walters, A., Chen, T., Buchanan, G., Frenkel, B. and Coetzee, G.A. (2008) Genomic androgen receptor-occupied regions with different functions, defined by histone acetylation, coregulators and transcriptional capacity. PLoS One, 3, e3645.
15. Takayama, K., Kaneshiro, K., Tsutsumi, S., Horie-Inoue, K., Ikeda, K., Urano, T., Ijichi, N., Ouchi, Y., Shirahige, K., Aburatani, H. et al. (2007) Identification of novel androgen response genes in prostate cancer cells by coupling chromatin immunoprecipitation and genomic microarray analysis. Oncogene, 26, 4453-4463.
16. Metzger, E., Wissmann, M., Yin, N., Muller, J.M., Schneider, R., Peters, A.H., Gunther, T., Buettner, R. and Schule, R. (2005) LSD1 demethylates repressive histone marks to promote androgenreceptor-dependent transcription. Nature, 437, 436-439.
17. Ahlqvist, K., Saamarthy, K., Sayed Khaja, A.S., Bjartell, A. and Massouimi, R. (2013) Expression of Id proteins is regulated by Bcl-3 proto-oncogene in prostate cancer. Oncogene, 32, 1601-1608.
18. Bruce, A.W., Donaldson, I.J., Wood, I.C., Yerbury, S.A., Sadowski, M.I., Chapman, M., Gottgens, B. and Buckley, N.J. (2004) Genome-wide analysis of repressor element 1 silencing transcription factor/neuron-restrictive silencing factor (REST/NRSF) target genes. Proc. Natl Acad. Sci. USA, 101, 10458-10463.
19. Lenhard, B. and Wasserman, W.W. (2002) TFBS: computational framework for transcription factor binding site analysis. Bioinformatics (Oxford, England), 18, 1135-1136.
20. Vidal, O.M., Merino, R., Rico-Bautista, E., Fernandez-Perez, L., Chia, D.J., Woelfle, J., Ono, M., Lenhard, B., Norstedt, G., Rotwein, P. et al. (2007) In vivo transcript profiling and phylogenetic analysis identifies suppressor of cytokine signaling 2 as a direct signal transducer and activator of transcription 5b target in liver. Mol. Endocrinol., 21, 293-311.
21. Sandelin, A., Alkema, W., Engstrom, P., Wasserman, W.W. and Lenhard, B. (2004) JASPAR: an open-access database for eukaryotic transcription factor binding profiles. Nucleic Acids Res., 32, D91-D94.
22. Chuan, Y.C., Iglesias-Gato, D., Fernandez-Perez, L., Cedazo-Minguez, A., Pang, S.T., Norstedt, G., Pousette, A. and Flores-Morales, A. (2010) Ezrin mediates c-Myc actions in prostate cancer cell invasion. Oncogene, 29, 1531-1542.
23. Chuan, Y.C., Pang, S.T., Cedazo-Minguez, A., Norstedt, G., Pousette, A. and Flores-Morales, A. (2006) Androgen induction of prostate cancer cell invasion is mediated by ezrin. J. Biol. Chem., 281, 29938-29948.
24. Ceder, J.A., Jansson, L., Helczynski, L. and Abrahamsson, P.A. (2008) Delta-like 1 (Dlk-1), a novel marker of prostate basal and candidate epithelial stem cells, is downregulated by notch signalling in intermediate/transit amplifying cells of the human prostate. Eur. Urol., 54, 1344-1353.
25. Tusher, V.G., Tibshirani, R. and Chu, G. (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl Acad. Sci. USA, 98, 5116-5121.
26. Saeed, A.I., Bhagabati, N.K., Braisted, J.C., Liang, W., Sharov, V., Howe, E.A., Li, J., Thiagarajan, M., White, J.A. and Quackenbush, J. (2006) TM4 microarray software suite. Methods Enzymol., 411, 134-193.
27. Zhao, J.C., Yu, J., Runkle, C., Wu, L., Hu, M., Wu, D., Liu, J.S., Wang, Q. and Qin, Z.S. (2012) Cooperation between Polycomb and androgen receptor during oncogenic transformation. Genome Res., 22, 322-331.
28. Mukhopadhyay, N.K., Cinar, B., Mukhopadhyay, L., Lutchman, M., Ferdinand, A.S., Kim, J., Chung, L.W., Adam, R.M., Ray, S.K., Leiter, A.B. et al. (2007) The zinc finger protein ras-responsive element binding protein-1 is a coregulator of the androgen receptor: implications for the role of the Ras pathway in enhancing androgenic signaling in prostate cancer. Mol. Endocrinol., 21, 2056-2070.
29. Mukhopadhyay, N.K., Ferdinand, A.S., Mukhopadhyay, L., Cinar, B., Lutchman, M., Richie, J.P., Freeman, M.R. and Liu, B.C. (2006) Unraveling androgen receptor interactomes by an arraybased method: discovery of proto-oncoprotein c-Rel as a negative regulator of androgen receptor. Exp. Cell Res., 312, 3782-3795.
30. Ballas, N. and Mandel, G. (2005) The many faces of REST oversee epigenetic programming of neuronal genes. Curr. Opin. Neurobiol., 15, 500-506.
31. Mulligan, P., Westbrook, T.F., Ottinger, M., Pavlova, N., Chang, B., Macia, E., Shi, Y.J., Barretina, J., Liu, J., Howley, P.M. et al. (2008) CDYL bridges REST and histone methyltransferases for gene repression and suppression of cellular transformation. Mol. Cell, 32, 718-726.
32. Westbrook, T.F., Hu, G., Ang, X.L., Mulligan, P., Pavlova, N.N., Liang, A., Leng, Y., Maehr, R., Shi, Y., Harper, J.W. et al. (2008) SCFbeta-TRCP controls oncogenic transformation and neural differentiation through REST degradation. Nature, 452, 370-374.
33. Zuccato, C., Tartari, M., Crotti, A., Goffredo, D., Valenza, M., Conti, L., Cataudella, T., Leavitt, B.R., Hayden, M.R., Timmusk, T. et al. (2003) Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes. Nat. Genet., 35, 76-83.
34. Holter, E., Kotaja, N., Makela, S., Strauss, L., Kietz, S., Janne, O.A., Gustafsson, J.A., Palvimo, J.J. and Treuter, E. (2002) Inhibition of androgen receptor (AR) function by the reproductive orphan nuclear receptor DAX-1. Mol. Endocrinol., 16, 515-528.
35. Jarvius, M., Paulsson, J., Weibrecht, I., Leuchowius, K.J., Andersson, A.C., Wahlby, C., Gullberg, M., Botling, J., Sjoblom, T., Markova, B. et al. (2007) In situ detection of phosphorylated platelet-derived growth factor receptor beta using a generalized proximity ligation method. Mol. Cell. Proteomics, 6, 1500-1509.
36. Dietrich, N., Lerdrup, M., Landt, E., Agrawal-Singh, S., Bak, M., Tommerup, N., Krappsilber, J., So?dersten, E. and Hansen, K. (2012) REST-mediated recruitment of polycomb repressor complexes in mammalian cells. PLoS Genet, 8, e1002494.
37. Guardavaccaro, D., Frescas, D., Dorrello, N.V., Peschiaroli, A., Multani, A.S., Cardozo, T., Lasorella, A., Iavarone, A., Chang, S., Hernando, E. et al. (2008) Control of chromosome stability by the beta-TrCP-REST-Mad2 axis. Nature, 452, 365-369.
38. Lapuk, A.V., Wu, C., Wyatt, A.W., McPherson, A., McConeghy, B.J., Brahmbhatt, S., Mo, F., Zoubeidi, A., Anderson, S., Bell, R.H. et al. (2012) From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancer. J. Pathol., 227, 286-297.
39. Abrahamsson, P.A. (1999) Neuroendocrine cells in tumour growth of the prostate. Endocr. Relat. Cancer, 6, 503-519.
40. Johnson, D.S., Mortazavi, A., Myers, R.M. and Wold, B. (2007) Genome-wide mapping of in vivo protein-DNA interactions. Science, 316, 1497-1502.
41. Subramanian, A., Tamayo, P., Mootha, V.K., Mukherjee, S., Ebert, B.L., Gillette, M.A., Paulovich, A., Pomeroy, S.L., Golub, T.R., Lander, E.S. et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA, 102, 15545-15550.
42. Kim, J. and Coetzee, G.A. (2004) Prostate specific antigen gene regulation by androgen receptor. J. Cell. Biochem., 93, 233-241.
43. Andreu-Vieyra, C., Lai, J., Berman, B.P., Frenkel, B., Jia, L., Jones, P.A. and Coetzee, G.A. (2011) Dynamic nucleosomedepleted regions at androgen receptor enhancers in the absence of ligand in prostate cancer cells. Mol. Cell. Biol., 31, 4648-4662.
44. Wang, Q., Li, W., Zhang, Y., Yuan, X., Xu, K., Yu, J., Chen, Z., Beroukhim, R., Wang, H., Lupien, M. et al. (2009) Androgen receptor regulates a distinct transcription program in androgenindependent prostate cancer. Cell, 138, 245-256.
45. Irvine, R.A., Ma, H., Yu, M.C., Ross, R.K., Stallcup, M.R. and Coetzee, G.A. (2000) Inhibition of p160-mediated coactivation with increasing androgen receptor polyglutamine length. Hum. Mol. Genet., 9, 267-274.
46. Aarnisalo, P., Palvimo, J.J. and Janne, O.A. (1998) CREB-binding protein in androgen receptor-mediated signaling. Proc. Natl Acad. Sci. USA, 95, 2122-2127.
47. Fu, M., Wang, C., Reutens, A.T., Wang, J., Angeletti, R.H., Siconolfi-Baez, L., Ogryzko, V., Avantaggiati, M.L. and Pestell, R.G. (2000) p300 and p300/cAMP-response element-binding protein-associated factor acetylate the androgen receptor at sites governing hormonedependent transactivation. J. Biol. Chem., 275, 20853-20860.
48. Jia, L., Shen, H.C., Wantroba, M., Khalid, O., Liang, G., Wang, Q., Gentzschein, E., Pinski, J.K., Stanczyk, F.Z., Jones, P.A. et al. (2006) Locus-wide chromatin remodeling and enhanced androgen receptor-mediated transcription in recurrent prostate tumor cells. Mol. Cell. Biol., 26, 7331-7341.
49. Yu, J., Mani, R.S., Cao, Q., Brenner, C.J., Cao, X., Wang, X., Wu, L., Li, J., Hu, M., Gong, Y. et al. (2010) An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression. Cancer Cell, 17, 443-454.
50. Zheng, D., Zhao, K. and Mehler, M.F. (2009) Profiling RE1/RESTmediated histone modifications in the human genome. Genome Biol., 10, R9.
51. Buchanan, G., Need, E.F., Barrett, J.M., Bianco-Miotto, T., Thompson, V.C., Butler, L.M., Marshall, V.R., Tilley, W.D. and Coetzee, G.A. (2011) Corepressor effect on androgen receptor activity varies with the length of the CAG encoded polyglutamine repeat and is dependent on receptor/corepressor ratio in prostate cancer cells. Mol. Cell. Endocrinol., 342, 20-31.
52. Huang, Z.Q., Li, J., Sachs, L.M., Cole, P.A. and Wong, J. (2003) A role for cofactor-cofactor and cofactor-histone interactions in targeting p300, SWI/SNF and Mediator for transcription. EMBO J., 22, 2146-2155.
53. Vashchenko, N. and Abrahamsson, P.A. (2005) Neuroendocrine differentiation in prostate cancer: implications for new treatment modalities. Eur. Urol., 47, 147-155.
54. DaSilva, J.O., Amorino, G.P., Casarez, E.V., Pemberton, B. and Parsons, S.J. (2013) Neuroendocrine-derived peptides promote prostate cancer cell survival through activation of IGF-1R signaling. Prostate, 73, 801-812.
55. Sauer, C.G., Roemer, A. and Grobholz, R. (2006) Genetic analysis of neuroendocrine tumor cells in prostatic carcinoma. Prostate, 66, 227-234.
56. Hendriksen, P.J., Dits, N.F., Kokame, K., Veldhoven, A., van Weerden, W.M., Bangma, C.H., Trapman, J. and Jenster, G. (2006) Evolution of the androgen receptor pathway during progression of prostate cancer. Cancer Res., 66, 5012-5020.
57. Wagoner, M.P., Gunsalus, K.T., Schoenike, B., Richardson, A.L., Friedl, A. and Roopra, A. (2010) The transcription factor REST is lost in aggressive breast cancer. PLoS Genet., 6, e1000979.
58. Malik, S.N., Brattain, M., Ghosh, P.M., Troyer, D.A., Prihoda, T., Bedolla, R. and Kreisberg, J.I. (2002) Immunohistochemical demonstration of phospho-Akt in high Gleason grade prostate cancer. Clin. Cancer Res., 8, 1168-1171.
59. Beltran, H., Rickman, D.S., Park, K., Chae, S.S., Sboner, A., MacDonald, T.Y., Wang, Y., Sheikh, K.L., Terry, S., Tagawa, S.T. et al. (2011) Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets. Cancer Discov., 1, 487-495.